Trial Identifier: | D6015C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02482311 |
Start Date: | July 2015 |
Primary Completion Date: | January 2018 |
Study Completion Date: | August 2019 |
Condition: | Ovarian Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Translation | |
French Translation |
Country | Location |
---|---|
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |
US, TN | Nashville, TN, US, 37203 |